Lupin Atlantis Holdings filed suit against Apotex and Ethypharm over two patents related to pharmaceutical compositions comprising micronized fenofibrate to treat patient conditions of hypertriglyceridemia and/or hypercholesterolemia and/or hyperlipidemia. 3/18, District of Delaware, 1:2011cv00234
Access to the full article is currently available to RPX members only. Please contact us if you need further information.
